Sanofi
SNY | NASDAQ
$44.34
+$1.21 (+2.81%)
At close: Oct 30, 2026, 4:00 PM ET
$44.36
+$0.02 (+0.05%)
Pre-market:
Nov 2, 2026, 7:20 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 48.92B | 47.35B | 46.72B | 42.14B | 43.13B | 43.77B | 42.89B | 47.46B | 46.01B | 45.31B | 46.44B | 45.7B | 46.14B | 46.2B | 45.39B | 44.35B | 42.04B | 40.34B | 39.18B | 38.5B | 37.55B | 36.94B |
Cost of Revenue | 13.2B | 13.17B | 12.92B | 11.56B | 12.24B | 12.66B | 12.74B | 14.51B | 14.27B | 14.13B | 14.24B | 13.92B | 13.91B | 13.89B | 13.7B | 13.44B | 12.85B | 12.45B | 12.26B | 12.22B | 12.16B | 11.98B |
Gross Profit | 35.72B | 34.18B | 33.79B | 30.58B | 30.89B | 31.12B | 30.16B | 32.95B | 31.74B | 31.18B | 32.21B | 31.78B | 32.23B | 32.31B | 31.69B | 30.91B | 29.19B | 27.89B | 26.92B | 26.28B | 25.39B | 24.96B |
Operating Income | 7.24B | 6.33B | 6.29B | 7.9B | 7.92B | 8.04B | 7.04B | 6.81B | 6.38B | 6.65B | 7.88B | 11.64B | 11.15B | 10.72B | 10.66B | 8.02B | 8.33B | 8.46B | 8.12B | 8.13B | 7.62B | 14.13B |
Interest Income | 274.69M | 352.45M | 378.45M | 539.79M | 558.79M | 662.87M | 723.87M | 818.96M | 828.96M | 828.71M | 842.71M | 703.83M | 612.83M | 378.25M | 227.25M | 87.03M | 37.03M | 15.05M | 19.05M | 25.74M | -918.81K | 25.43M |
Pretax Income | 5.2B | 5.83B | 6.02B | 7.63B | 7.7B | 7.65B | 6.54B | 5.84B | 5.36B | 5.66B | 7.04B | 11.37B | 10.94B | 10.61B | 10.49B | 7.82B | 8.08B | 8.19B | 7.83B | 7.81B | 7.32B | 13.99B |
Net Income | 3.96B | 7.56B | 7.81B | 9.11B | 9.13B | 6.3B | 5.56B | 4.51B | 4.22B | 4.54B | 5.4B | 9.07B | 8.62B | 8.36B | 8.37B | 6.39B | 6.62B | 6.66B | 6.22B | 6.15B | 5.79B | 12.18B |
Selling & General & Admin | 9.82B | 9.82B | 9.71B | 8.55B | 8.94B | 8.97B | 8.69B | 10.38B | 10.28B | 10.2B | 10.69B | 10.66B | 10.72B | 10.72B | 10.49B | 10.36B | 9.98B | 9.74B | 9.55B | 9.4B | 9.31B | 9.24B |
Research & Development | 8.11B | 7.78B | 7.84B | 7.67B | 7.69B | 7.48B | 7.35B | 7.1B | 6.91B | 6.84B | 6.73B | 6.68B | 6.75B | 6.78B | 6.71B | 6.47B | 6.18B | 5.92B | 5.69B | 5.62B | 5.5B | 5.46B |
Other Expenses | 10.56B | 10.26B | 9.95B | 6.45B | 6.35B | 6.63B | 7.09B | 8.67B | 8.17B | 7.5B | 6.91B | 2.81B | 3.61B | 4.08B | 3.84B | 6.06B | 4.71B | 3.78B | 3.56B | 3.13B | 2.96B | -3.86B |
Operating Expenses | 28.48B | 27.85B | 27.5B | 22.68B | 22.98B | 23.08B | 23.12B | 26.14B | 25.35B | 24.53B | 24.33B | 20.14B | 21.08B | 21.58B | 21.04B | 22.89B | 20.86B | 19.44B | 18.8B | 18.15B | 17.77B | 10.84B |
Interest Expense | 591.41M | 505.78M | 540.78M | 943.49M | 981.49M | 1.08B | 1.12B | 1.11B | 1.16B | 1.08B | 1.01B | 917.16M | 702.16M | 660M | 580M | 552.84M | 536.84M | 544.04M | 555.04M | 577.33M | 373.22M | 431.84M |
Selling & Marketing Expenses | 336M | 167M | 169M | 169M | 169M | 169M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.68B | 41.03B | 40.42B | 34.24B | 35.21B | 35.74B | 35.86B | 40.66B | 39.62B | 38.66B | 38.57B | 34.06B | 34.99B | 35.48B | 34.73B | 36.32B | 33.71B | 31.89B | 31.06B | 30.37B | 29.93B | 22.81B |
Income Tax Expense | 1.2B | 982M | 1.04B | 1.4B | 1.45B | 1.52B | 1.14B | 1.45B | 1.28B | 1.25B | 1.6B | 2.2B | 2.24B | 2.13B | 2.01B | 1.36B | 1.37B | 1.48B | 1.56B | 1.61B | 1.5B | 1.78B |
Shares Outstanding (Basic) | 2.39B | 2.41B | 2.44B | 2.44B | 2.47B | 2.47B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B |
Shares Outstanding (Diluted) | 2.39B | 2.41B | 2.44B | 2.47B | 2.47B | 2.47B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B | 2.51B | 2.51B | 2.5B | 2.5B |
EPS (Basic) | 0.48 | 1.94 | 2.03 | 3.85 | 3.83 | 2.68 | 2.37 | 1.81 | 1.69 | 1.82 | 2.16 | 3.62 | 3.45 | 3.34 | 3.35 | 2.56 | 2.65 | 2.66 | 2.48 | 2.46 | 2.31 | 4.86 |
EPS (Diluted) | 0.48 | 1.94 | 2.03 | 3.84 | 3.83 | 2.68 | 2.37 | 1.81 | 1.69 | 1.82 | 2.16 | 3.62 | 3.45 | 3.34 | 3.35 | 2.56 | 2.65 | 2.67 | 2.49 | 2.47 | 2.32 | 4.86 |
EBITDA | 12.41B | 12.63B | 12.68B | 9.42B | 9.47B | 9.61B | 8.7B | 8.57B | 8.23B | 8.68B | 9.93B | 14.44B | 13.99B | 13.43B | 13.17B | 10.17B | 10.13B | 10.19B | 9.79B | 11.28B | 11.3B | 17.82B |
EBIT | 8.89B | 9.28B | 9.47B | 7.97B | 8B | 8.02B | 7.03B | 6.53B | 6.11B | 6.52B | 7.76B | 12.16B | 11.59B | 11.11B | 10.89B | 8.16B | 8.41B | 8.55B | 8.21B | 8.16B | 7.74B | 14.22B |
Depreciation & Amortization | 3.52B | 3.35B | 3.21B | 1.45B | 1.47B | 1.59B | 1.67B | 2.04B | 2.12B | 2.17B | 2.17B | 2.28B | 2.4B | 2.32B | 2.28B | 2.02B | 1.72B | 1.64B | 1.58B | 3.12B | 3.56B | 3.6B |
Add to Watchlist
Select watchlists to add or remove SNY